Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy

Multiple myeloma (MM) is a malignancy of terminally differentiated plasma cells, and accounts for 10% of all hematologic malignancies and 1% of all cancers. MM is characterized by genomic instability which results from DNA damage with certain genomic rearrangements being prognostic factors for the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gkotzamanidou, Maria, Terpou, Elisavet, Kentepozidis, Nikolaos, Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508842/
https://www.ncbi.nlm.nih.gov/pubmed/34638744
http://dx.doi.org/10.3390/ijms221910406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508842/
https://www.ncbi.nlm.nih.gov/pubmed/34638744
http://dx.doi.org/10.3390/ijms221910406

Ejemplares similares